BioSpace News Archive

Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, reported consolidated financial results for the year ended December 31, 2021.

A ketogenic diet, which primarily consists of foods like meat, fish, eggs, heavy cream, butter, oils and non-starchy vegetables like pea pods, carrots, broccoli and peppers, may be safe for people with multiple sclerosis.

Following its robust safety data in the U.S. Phase I clinical study, ImmVira announced that its global first intravenous administered oncolytic herpes simplex virus (“oHSV”) product MVR-T3011 IV has completed first dosing on March 1, 2022 and initiated Phase I clinical trial in a series of well-known domestic clinical study centers in China.

IASO Biotherapeutics (“IASO Bio”), announced that the company’s commercial manufacturing facility in Nanjing successfully passed a comprehensive inspection by the Medical Products Administration of Province Jiangsu (JSMPA) and was granted a drug manufacturing license.

InnoCare Pharma, a leading biopharmaceutical company, announced the Investigational New Drug approval of its Bruton’s tyrosine kinase inhibitor orelabrutinib by China National Medical Products Administration to start phase II clinical trial in Neuromyelitis Optica Spectrum Disorder in China.